M&R Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $13.8M | Sell |
121,659
-3,220
| -3% | -$383K | 3.04% | 9 |
|
|
2024
Q2 | $15.5M | Buy |
124,879
+1,227
| +1% | +$158K | 3.69% | 6 |
|
|
2024
Q1 | $16.3M | Sell |
123,652
-1,813
| -1% | -$223K | 4% | 6 |
|
|
2023
Q4 | $13.7M | Sell |
125,465
-1,511
| -1% | -$157K | 3.42% | 7 |
|
|
2023
Q3 | $13.1M | Sell |
126,976
-807
| -0.6% | -$87K | 3.58% | 6 |
|
|
2023
Q2 | $14.7M | Buy |
127,783
+2,624
| +2% | +$298K | 3.85% | 6 |
|
|
2023
Q1 | $13.3M | Buy |
125,159
+516
| +0.4% | +$55.7K | 3.73% | 6 |
|
|
2022
Q4 | $13.8M | Sell |
124,643
-366
| -0.3% | -$37.4K | 3.8% | 6 |
|
|
2022
Q3 | $10.8M | Buy |
125,009
+299
| +0.2% | +$26.7K | 3.04% | 9 |
|
|
2022
Q2 | $11.4M | Sell |
124,710
-1,624
| -1% | -$144K | 2.97% | 9 |
|
|
2022
Q1 | $10.4M | Buy |
126,334
+2,339
| +2% | +$184K | 2.22% | 13 |
|
|
2021
Q4 | $9.5M | Sell |
123,995
-3,533
| -3% | -$281K | 1.97% | 17 |
|
|
2021
Q3 | $9.58M | Sell |
127,528
-337
| -0.3% | -$25.6K | 2.17% | 14 |
|
|
2021
Q2 | $9.94M | Sell |
127,865
-2,895
| -2% | -$215K | 2.28% | 13 |
|
|
2021
Q1 | $9.62M | Buy |
130,760
+110,954
| +560% | +$8.18M | 2.4% | 13 |
|
|
2020
Q4 | $1.55M | Sell |
19,806
-2,214
| -10% | -$169K | 0.35% | 52 |
|
|
2020
Q3 | $1.74M | Sell |
22,020
-310
| -1% | -$24.3K | 0.43% | 48 |
|
|
2020
Q2 | $1.65M | Sell |
22,330
-12,542
| -36% | -$944K | 0.44% | 48 |
|
|
2020
Q1 | $2.56M | Sell |
34,872
-3,269
| -9% | -$257K | 0.76% | 33 |
|
|
2019
Q4 | $3.31M | Buy |
38,141
+604
| +2% | +$49.6K | 0.74% | 36 |
|
|
2019
Q3 | $3.01M | Sell |
37,537
-1,044
| -3% | -$83.7K | 0.7% | 38 |
|
|
2019
Q2 | $3.04M | Buy |
38,581
+5
| +0% | +$383 | 0.69% | 41 |
|
|
2019
Q1 | $2.79M | Buy |
38,576
+1,947
| +5% | +$146K | 0.64% | 44 |
|
|
2018
Q4 | $2.64M | Sell |
36,629
-738
| -2% | -$52.1K | 0.69% | 40 |
|
|
2018
Q3 | $2.51M | Sell |
37,367
-49
| -0.1% | -$3.12K | 0.55% | 47 |
|
|
2018
Q2 | $2.17M | Sell |
37,416
-2,616
| -7% | -$148K | 0.5% | 52 |
|
|
2018
Q1 | $2.1M | Sell |
40,032
-1,335
| -3% | -$72.1K | 0.49% | 53 |
|
|
2017
Q4 | $2.24M | Buy |
41,367
+188
| +0.5% | +$10.4K | 0.52% | 47 |
|
|
2017
Q3 | $2.52M | Buy |
41,179
+1,520
| +4% | +$92.2K | 0.61% | 45 |
|
|
2017
Q2 | $2.36M | Buy |
39,659
+740
| +2% | +$45K | 0.59% | 46 |
|
|
2017
Q1 | $2.36M | Sell |
38,919
-959
| -2% | -$58.2K | 0.59% | 48 |
|
|
2016
Q4 | $2.24M | Buy |
39,878
+1,568
| +4% | +$91.8K | 0.6% | 46 |
|
|
2016
Q3 | $2.28M | Buy |
38,310
+5
| +0% | +$292 | 0.65% | 44 |
|
|
2016
Q2 | $2.1M | Buy |
38,305
+254
| +0.7% | +$13.5K | 0.62% | 47 |
|
|
2016
Q1 | $1.92M | Sell |
38,051
-2,382
| -6% | -$117K | 0.58% | 47 |
|
|
2015
Q4 | $2.04M | Buy |
40,433
+7,765
| +24% | +$391K | 0.59% | 44 |
|
|
2015
Q3 | $1.54M | Sell |
32,668
-3,185
| -9% | -$169K | 0.43% | 54 |
|
|
2015
Q2 | $1.95M | Buy |
35,853
+109
| +0.3% | +$6.11K | 0.46% | 54 |
|
|
2015
Q1 | $1.96M | Buy |
35,744
+925
| +3% | +$52.4K | 0.46% | 54 |
|
|
2014
Q4 | $1.89M | Sell |
34,819
-1,495
| -4% | -$83.3K | 0.45% | 55 |
|
|
2014
Q3 | $2.05M | Sell |
36,314
-207
| -0.6% | -$11.6K | 0.49% | 54 |
|
|
2014
Q2 | $2.02M | Sell |
36,521
-832
| -2% | -$45.4K | 0.47% | 50 |
|
|
2014
Q1 | $2.02M | Buy |
37,353
+1,075
| +3% | +$55.7K | 0.49% | 48 |
|
|
2013
Q4 | $1.73K | Sell |
36,278
-1,568
| -4% | -$71.7K | 0.45% | 48 |
|
|
2013
Q3 | $1.72M | Buy |
37,846
+342
| +0.9% | +$15.6K | 0.48% | 45 |
|
|
2013
Q2 | $1.66M | Buy |
+37,504
| New | +$1.68M | 0.48% | 47 |
|
Other funds holding MRK
M&R Capital Management's MRK Position: Q3 2024 in Review
M&R Capital Management reduced its Merck (MRK) stake by 2.6% in Q3 2024, selling an estimated $383K and leaving 121,659 shares worth $13.8M. The position accounts for 3.04% of the portfolio, ranked #9.
M&R Capital Management first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.3M in Q1 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- M&R Capital Management held 121,659 shares of Merck worth $13.8M as of Q3 2024.
- M&R Capital Management sold 3,220 Merck shares in Q3 2024, an estimated $383K.
- Merck made up 3.04% of M&R Capital Management's portfolio in Q3 2024, its #9 holding.
- M&R Capital Management first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
- M&R Capital Management's Merck position peaked at $16.3M in Q1 2024.
- 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.